After donating $176 million in proceeds from his original stock options in 2023, Stéphane Bancel is taking a different path ...

Moderna, Inc. has rallied ~23%, but rated a Sell due to deteriorating fundamentals. Learn more about MRNA stock here.

The latest trading day saw Moderna (MRNA) settling at $32.29, representing a -7.48% change from its previous close.

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 4% in the morning session after the company announced it would ...

Since that moment, Moderna has taken steps to pave the path to long-term growth -- from cutting costs to focusing on its vast ...

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 7.8% in the afternoon session after the stock's ...

Get the live share price of Moderna Inc (MRNA), including intraday charts, historical performance, key financials, and market updates. Track the latest US stock market activity.

Top large-cap gainers for Dec. 15–19 were led by Rivian, Moderna, and BioMarin, rising on product/software updates, vaccine ...

Nvidia (NVDA) shares recently found strong buying support at below $175. That led to an uptrend, followed by a 3.01% lift for ...

The Coalition for Epidemic Preparedness Innovations said it will invest $54.3 million with Moderna to fund a Phase 3 trial of ...

Moderna (MRNA) is back in the spotlight after securing up to $54.3 million from CEPI to help fund a Phase 3 trial of its H5 bird flu vaccine candidate, mRNA-1018. See our latest analysis for Moderna.

Momentum traders who seek fast-moving stocks have three to look at. Sandisk (SNDK) gained 15.2% in the last week. It trades ...